Clinical Trial Update: Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide

View source ↗

Summary

PharmaMar reports results from a trial of trabectedin in patients with advanced soft tissue sarcoma who failed prior anthracycline and/or ifosfamide therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: PharmaMar | Conditions: Soft Tissue Sarcoma | Status: COMPLETED